U.S. Congress - H.R.4056 Science and Technology Regulatory Relief Act of 2012
H.R.4056 - Science and Technology Regulatory Relief Act of 2012
To amend the Federal Food, Drug, and Cosmetic Act to prevent a State or political subdivision thereof from conducting or requiring duplicative inspections of establishments in which a drug or device is manufactured, processed, packed, or held by a manufacturer or wholesale distributor of the drug or device. view all titles (2)
All Bill Titles
- Official: To amend the Federal Food, Drug, and Cosmetic Act to prevent a State or political subdivision thereof from conducting or requiring duplicative inspections of establishments in which a drug or device is manufactured, processed, packed, or held by a manufacturer or wholesale distributor of the drug or device. as introduced.
- Short: Science and Technology Regulatory Relief Act of 2012 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 3
- Past Seven Days: 8
- All-Time: 751
|
|
|
|
|
|
|
|
Committees
Official Summary
2/16/2012--Introduced.Science and Technology Regulatory Relief Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a state or political subdivision from conducting or requiring an inspection of a factory, warehouse, or establishment in which a drug or device is manufaOfficial Summary
2/16/2012--Introduced.Science and Technology Regulatory Relief Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a state or political subdivision from conducting or requiring an inspection of a factory, warehouse, or establishment in which a drug or device is manufactured, processed, packed, or held by a manufacturer or wholesale distributor for introduction into interstate commerce, or after such introduction, for purposes of verifying compliance with such Act, Public Health Service Act requirements regarding the regulation of biological products, or any similar requirements established pursuant to state law. Makes exceptions for such an inspection if:(1) the state or subdivision makes a determination that a drug or device presents a threat of serious adverse health consequences or death;
(2) the Secretary of Health and Human Services (HHS) orders a recall of a drug, biological product, or device manufactured, processed, packed, or held at the factory, warehouse, or establishment; or
(3) the Secretary requests or authorizes the state to conduct or require the inspection.
...Read the Rest
Vote on This Bill
-
Share This Bill
More Share via Email
